Concepedia

Author

C. Michel Zwaan

Erasmus MC - Sophia Children’s HospitalORCID

Also Known As

C M Zwaan, C Michel Zwaan, C ZWAAN, C Zwaan, C. M Zwaan, C. M. Zwaan, C. Michel Zwaan, C. Zwaan, C.M. Zwaan, Christian M Zwaan

292

Publications

10.4K

Citations

52

H-Index

70

Concepts

All Affiliations

Erasmus MC - Sophia Children’s HospitalPrincess Máxima CenterStichting Kinderoncologie NederlandErasmus MCAmsterdam UMC Location Vrije Universiteit Amsterdam
CM

About

C. Michel Zwaan is an author at Erasmus MC - Sophia Children’s Hospital specializing in medicine, pathology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

28

2.8K

2

Health Sciences

3

3

189

3

Engineering

2

2

59

4

Natural Sciences

1

1

19

5

Public Health

1

1

16

C. Michel Zwaan

×

101

Publications

8.1K

Citations

47

H-Index

YearCitations

The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions

Hamid Bolouri, Jason E. Farrar, Timothy J. Triche,

Nature Medicine

2017

850

The MLL recombinome of acute leukemias in 2017

Claus Meyer, Thomas Burmeister, Daniela Gröger,

Leukemia

2017

670

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Arend von Stackelberg, Franco Locatelli, Gerhard Zugmaier,

Journal of Clinical Oncology

2016

597

NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern

Iris H.I.M. Hollink, Marry M. van den Heuvel‐Eibrink, Susan T.C.J.M. Arentsen-Peters,

Blood

2011

327

HOXA9 is required for survival in human MLL-rearranged acute leukemias

Joerg Faber, Andrei V. Krivtsov, Matthew C. Stubbs,

Blood

2008

327

Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group

Trudy Buitenkamp, Shai Izraeli, Martin Zimmermann,

Blood

2013

242

The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets

Cornelis M. van Tilburg, Elke Pfaff, Kristian W. Pajtler,

Cancer Discovery

2021

236

Pediatric non–Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes

Jasmijn de Rooij, Cristyn Branstetter, Jing Ma,

Nature Genetics

2017

219

Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling

Jean‐Pierre Bourquin, Aravind Subramanian, Claudia Langebrake,

Proceedings of the National Academy of Sciences

2006

184

Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML

Iris H.I.M. Hollink, C. Michel Zwaan, Martin Zimmermann,

Leukemia

2008

162

Page 1